Emergency Department-initiated High-flow Nasal Cannula for COVID-19 Respiratory Distress.

ABSTRACT:

Introduction

Patients with coronavirus disease 2019 (COVID-19) can develop rapidly progressive respiratory failure. Ventilation strategies during the COVID-19 pandemic seek to minimize patient mortality. In this study we examine associations between the availability of emergency department (ED)-initiated high-flow nasal cannula (HFNC) for patients presenting with COVID-19 respiratory distress and outcomes, including rates of endotracheal intubation (ETT), mortality, and hospital length of stay.

Methods

We performed a retrospective, non-concurrent cohort study of patients with COVID-19 respiratory distress presenting to the ED who required HFNC or ETT in the ED or within 24 hours following ED departure. Comparisons were made between patients presenting before and after the in

SUBMITTER: Jarou ZJ 

PROVIDER: S-EPMC8328178 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature